The substantial decrease in losses per share for iBio suggests a strong improvement in the company's financial health and operational efficiency. This positive change is likely to be viewed favorably by investors, potentially leading to an increase in stock price in the short term. The magnitude of improvement (92.55%) is significant enough to catch investor attention and may lead to increased investor confidence in the company's direction and management.